All companies
Visit website
SunState Laboratories
OperatingSunState Laboratories, Inc.
Founded 2020
DAZZ Cleaning Tablets – Save Money, Plastic, and the Earth
Post-money valuation ⓘ
$12.2M
As of Feb 2022 · from SUNSTATE LABORATORIES Preferred Stock 2 · pre-money + amount raised, not a traded price
Total raised
$1,235,950
Across 3 rounds since 2020
Latest share price
$12.63
SUNSTATE LABORATORIES Preferred Stock 2 offering price
Financials
FY2017–FY2022 · from SEC filings · hover any figure for its source$16K
−$22K
2017
$11K
−$41K
2018
$20K
−$54K
2019
$166K
−$376K
2020
$325K
−$511K
2021
$459K
−$58K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
Income statement
Revenue
$16,491
$10,623
$20,354
$165,911
$325,300
$459,423
Cost of goods sold
$4,617
$23,848
$13,173
$87,208
$121,281
$80,007
Gross margin
72%
-124%
35%
47%
63%
83%
Net income
-$21,619
-$40,562
-$53,544
-$375,621
-$510,608
-$58,384
Taxes paid
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$14,233
$6,271
$7,952
$493,028
$64,339
$73,416
Accounts receivable
$0
$0
$0
$17,179
$47,357
$69,738
Total assets
$108,517
$72,262
$85,716
$689,425
$272,602
$320,113
Short-term debt
$571
$3,460
$18,606
$26,309
$55,953
$3,630
Long-term debt
$0
$0
$0
$0
$107,925
$97,925
Total liabilities
$571
$3,460
$18,606
$26,309
$163,877
$101,555
Other
Headcount
—
1
—
4
—
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$6.1M
post-money
$12.2M
post-money
SunState Laboratories Stock 1
SUNSTATE LABORATORIES Preferred Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $166K / $3MInvestors 183Post-money $12.2M
Raised $1.1M / $1.1MInvestors 1,680Post-money $6.1M
Reg CF Offering (2020)Closed
Reg CF annual-report compliance
Delinquent
Filed 2 of 7 annual reports (FY2019–FY2025)
Missing: 2019, 2021, 2023, 2024, 2025
1,680 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001800204Share price $12.63
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.